Stay updated on Nivolumab in Relapsed/Refractory DLBCL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Updated the Italy location from Napoli to Naples (Naples, Italy, 80131) and added Naples, Italy, 80131 as a location. The page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T19:47:01.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T15:55:32.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    - Site revision updated from v3.4.1 to v3.4.2. No study content or user-facing details were changed.
    Difference
    0.0%
    Check dated 2026-02-12T15:22:37.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page.
    Difference
    0.0%
    Check dated 2026-02-05T11:01:25.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Added: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-29T03:45:29.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    The update adds a minor revision label v3.3.4 and removes the previous v3.3.3 label from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:52:08.000Z thumbnail image

Stay in the know with updates to Nivolumab in Relapsed/Refractory DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page.